High doses of ketamine can temporarily switch off the brain, say...

Researchers have identified two brain phenomena that may explain some of the side-effects of ketamine. Their measurements of the brain waves of sheep sedated by...

Antihistamines and similar drugs could slow down Huntington’s disease

Controlling dopamine signalling by targeting the histamine receptor has been shown to be a promising strategy for preventing the progression of Huntington’s disease in...

NEUROBIOLOGY OF DISEASE PUBLISHES ENCOURAGING PRECLINICAL RESULTS OF AFFIRIS’ ANTIBODY MAB...

Neurobiology of Disease publishes encouraging preclinical results of AFFiRiS’ antibody mAB C6-17 to treat Huntington’s disease Monoclonal antibody mAB C6-17 targeting human/mutant huntingtin protein...

Research highlights immune molecule’s complex role in Huntington’s disease

More than a decade before people with Huntington’s disease show symptoms, they can exhibit abnormally high levels of an immune-system molecule called interleukin-6 (IL-6),...

Optimal time to treat Huntington’s disease identified

The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study The researchers...